Home
Issues
Aim & Scope
Open Access
Editorial Board
Indexing
Supporting Midwifery Associations
Contact us
Manuscript Types
Manuscript Formatting
How to submit
Special publications and Reprints
Authorship & COI
Principles of Transparency Checklist
Publication Ethics and Publication Malpractice Statement
CONFERENCE PROCEEDING
Transforming neonatal jaundice detection: Results from a mixed-methods randomized controlled feasibility study in a resource-limited Mexican setting
1
Picterus AS, Medical Advisor, Trondheim, Norway
2
Instituto Mexicano del Seguro Social, Health Research Coordination, Oaxaca, Mexico
3
Norwegian University of Science and Technology, Department of Design- Faculty of Architecture and Design, Trondheim, Norway
4
Picterus AS, Medical department, Trondheim, Norway
5
Norwegian University of Science and Technology, Department of Public Health and Nursing- Faculty of Medicine and Health Sciences, Trondheim, Norway
Eur J Midwifery 2026;10(Supplement 1):A550
ABSTRACT
BACKGROUND:
Neonatal jaundice is a common and often mild condition, but about 10% of cases can develop into severe forms that may lead to irreversible brain damage or even death if not detected and treated promptly. The rate of severe cases is higher in resource-limited settings due to restricted access to reliable diagnostic tools.
OBJECTIVES:
Evaluate the feasibility of using Picterus Jaundice Pro, a smartphone-based tool for detecting neonatal jaundice, in a resource-limited Mexican healthcare setting.
METHODS:
A randomized controlled trial and qualitative assessment were conducted. Newborns were assigned either to standard visual assessment alone (control group) or to visual assessment plus Picterus Jaundice Pro (intervention group). Key outcomes included the number of positive screenings, successful emergency room referrals (bilirubin ≥ 14.6 mg/dL [250 μmol/L]), treatment requirements, and treatments received. Feasibility was measured by recruitment rates, device usability, and adherence to the study protocol.
RESULTS:
Between January and June 2024, 542 newborns participated (273 in the control group, 269 in the intervention group). Use of Picterus Jaundice Pro significantly increased (proportional difference [95% Confidence Interval]): positive screening rates (0.299 [0.230–0.362]), successful referrals (0.112 [0.058–0.166]), treatment needs (0.045 [0.008–0.082]), and treatments received (0.038 [0.003–0.072]). The device was found to be user-friendly, integrated smoothly into clinical workflows, and achieved high protocol adherence. However, 11% of referrals were not completed due to logistical challenges and parents’ low perception of risk.
CONCLUSIONS:
Picterus Jaundice Pro improves screening for neonatal jaundice in low-resource environments, but overcoming systemic barriers and increasing awareness among parents and healthcare professionals is essential to achieving better outcomes for newborns.
KEY MESSAGE:
The use of smartphone-based tools like Picterus Jaundice Pro in settings with limited resources greatly improves the early detection and care of newborn jaundice. These mHealth solutions are vital for closing healthcare gaps in places where standard diagnostic equipment is lacking. Poster session 1 (Group A)
Neonatal jaundice is a common and often mild condition, but about 10% of cases can develop into severe forms that may lead to irreversible brain damage or even death if not detected and treated promptly. The rate of severe cases is higher in resource-limited settings due to restricted access to reliable diagnostic tools.
OBJECTIVES:
Evaluate the feasibility of using Picterus Jaundice Pro, a smartphone-based tool for detecting neonatal jaundice, in a resource-limited Mexican healthcare setting.
METHODS:
A randomized controlled trial and qualitative assessment were conducted. Newborns were assigned either to standard visual assessment alone (control group) or to visual assessment plus Picterus Jaundice Pro (intervention group). Key outcomes included the number of positive screenings, successful emergency room referrals (bilirubin ≥ 14.6 mg/dL [250 μmol/L]), treatment requirements, and treatments received. Feasibility was measured by recruitment rates, device usability, and adherence to the study protocol.
RESULTS:
Between January and June 2024, 542 newborns participated (273 in the control group, 269 in the intervention group). Use of Picterus Jaundice Pro significantly increased (proportional difference [95% Confidence Interval]): positive screening rates (0.299 [0.230–0.362]), successful referrals (0.112 [0.058–0.166]), treatment needs (0.045 [0.008–0.082]), and treatments received (0.038 [0.003–0.072]). The device was found to be user-friendly, integrated smoothly into clinical workflows, and achieved high protocol adherence. However, 11% of referrals were not completed due to logistical challenges and parents’ low perception of risk.
CONCLUSIONS:
Picterus Jaundice Pro improves screening for neonatal jaundice in low-resource environments, but overcoming systemic barriers and increasing awareness among parents and healthcare professionals is essential to achieving better outcomes for newborns.
KEY MESSAGE:
The use of smartphone-based tools like Picterus Jaundice Pro in settings with limited resources greatly improves the early detection and care of newborn jaundice. These mHealth solutions are vital for closing healthcare gaps in places where standard diagnostic equipment is lacking. Poster session 1 (Group A)
| eISSN: | 2585-2906 |
We process personal data collected when visiting the website. The function of obtaining information about users and their behavior is carried out by voluntarily entered information in forms and saving cookies in end devices. Data, including cookies, are used to provide services, improve the user experience and to analyze the traffic in accordance with the Privacy policy. Data are also collected and processed by Google Analytics tool (more).
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
You can change cookies settings in your browser. Restricted use of cookies in the browser configuration may affect some functionalities of the website.
